BULLETIN V2025-3609
PHARMACORP RX INC. ("PCRX") ("PCRX.WT")
BULLETIN TYPE: Prospectus-Unit Offering, New Listing-Warrants
BULLETIN DATE: November 13, 2025
TSX Venture Tier 2 Company
Financing Type: Bought Deal Prospectus Offering
Gross Proceeds: $20,039,100.00
Offering: 54,855,000 Listed Shares with 27,427,500 Warrants
Offering Price: $0.42 per Unit
Warrant Exercise Terms: $0.50 per Listed Share until November 12, 2027.
Overallotment Option: The underwriters may purchase a maximum of 7,155,000 Units, 7,155,000 Listed Share, or 3,577,500 Listed Warrants for overallotment purposes. As of November 12, 2025, such option has been fully exercised. All information presented herein includes such exercise.
Commissions in Securities: # Broker Warrants
(Aggregate # of Brokers: 5) 2,026,130
Broker Warrant Terms: Each Broker Warrant is non-transferable and exercisable into (1) Broker Unit at $0.42 for a period of 12 months from the date of issuance. Each Broker Unit is comprised of (1) Listed Share and (1/2) Warrant. Each whole Warrant is exercisable at an exercise price of $0.50 until November 12, 2027.
Disclosure: Refer to the prospectus dated November 7, 2025 and company's news release(s) dated October 17, 2025, November 5, 2025, November 6, 2025 and November 12, 2025.
New Listing-Warrants
Effective at the opening on Monday, November 17, 2025, the Warrants of the Company will commence trading on TSX Venture Exchange. The Company is classified as an 'Health and Personal Care Stores' company.
Corporate Jurisdiction: Saskatchewan
Capitalization: Up to 28,661,737 Warrants, authorized by a Warrant Indenture dated November 12, 2025 of which 27,427,500 Warrants are issued and outstanding.
Warrants Exercise Terms: Each Warrant entitles the holder thereof to acquire one (1) Listed Share at an exercise price of $0.50 per Listed Share, until November 12, 2027.
Transfer Agent: TSX Trust Company
Trading Symbol: PCRX.WT (NEW)
CUSIP Number: 71714X 11 3 (NEW)
Disclosure: Refer to the prospectus dated November 7, 2025 and company's news release(s) dated November 12 and November 13, 2025.
_______________________________________
|
|
